Biological Treatments for Autism and PDD Online > Chapter 3: Part I | Part II | Part III

Buy The newest version (2002) of this book online!

Arabinose, pentosidine, and protein crosslinks

The aldehyde group of arabinose can react with the extra amino chemical group(called an epsilon amino group) of an amino acid called lysine that is present in a wide variety of proteins. This combined arabinose-lysine molecule may then form cross-links with an amino acid called arginine in an adjoining protein (25), forming a compound called a pentosidine (Figures10 A,B,C). The formation of a pentosidine may cross-link different proteins (Figure 11) and may alter both the biological structure and function of a wide variety of proteins(25). The effect on all of the body's functions may be devastating.

Top

Let's use the LA freeway analogy again to understand. Suppose that on a very foggy day during the rush hour Gremlins hiding under your moving car and those of your neighbors took strong steel bars and welded them to the frames of the moving cars. The steel bars stick out at a perpendicular angle for about three feet from the side of your car without you or any other driver noticing because of the fog. Arabinose would be like the steel bar and the proteins would be like the cars. Suppose the gremlins welded the other end of the steel bars to the frames of neighboring cars. Then suppose they welded a bar between that neighboring car and a third car and so forth. Furthermore, some cars might be welded to each other by their bumpers in addition to their sides. Now imagine what will happen when one or more of the drivers wanted to exit or change lanes. Chaos and carnage would ensue. The combined molecule of arabinose, lysine, and arginine is called a pentosidine and is like the two cars welded together. The undoing of these cross-links will become a major challenge in the future for treating older individuals with autism in which many of these cross-links have already been established.

I suspect that autism was reversed in the children of Pam Scott and Karyn Seroussi because they started therapy at a very young age. However, I have received reports of some improvements after antifungal therapy in people with autism in their twenties. Antifungal therapy cannot undo any of the cross-links; such therapy can only prevent the formation of new cross-links by reducing the production of yeast arabinose. The tissue concentration of this combined molecule is almost linearly related to age (25); the increase in crosslinks (steel bars) in this molecule is one of the main reasons we lose flexibility as we age.

One child with autism with a very high urine arabinose(1144 mmol/mol creatinine) was examined by MRI (a type of brain scan) and found to have diffuse demyelination (loss of myelin) of the white matter of the brain.(Values as high as 4000 mmol/mol creatinine have been found in children with autism who have not been eating apple products.) It is possible that pentosidine formation could account for this demyelination. Myelin is the material that covers the axons of the brain in much the same way that plastic insulating material is wrapped around copper electrical wire. Without an intact myelin cover, the nerve impulses in the brain are short-circuited just like an electrical wire with torn insulation. Most children with autism are not examined by MRI but such an examination on a research basis of children with high urine arabinose values might be helpful to prove a link between high arabinose and demyelination. A summary of the possible adverse effects of pentosidine is given in Table 1.

Top

Top

Arabinose and impaired vitamin function

The epsilon amino group of lysine is a critical functional group of many enzymes to which the vitamins pyridoxal (vitamin B-6), biotin, and lipoic acid are covalently bonded during coenzymatic reactions (26); the blockage of these active lysine sites by pentosidine formation may cause functional vitamin deficiencies (Figure12) even when nutritional intake is adequate. In addition, the epsilon amino groups of lysine may also be important in the active catalytic site of many enzymes.

Top

Pentosidines, tangled nerves, Alzheimer's disease, and autism

Protein modification caused by pentosidine formation is associated with crosslink formation, decreased protein solubility, and increased protease resistance. The characteristic pathological structures called neurofibrillary tangles associated with Alzheimer disease contain modifications typical of pentosidine formation. Specifically, antibodies against pentosidine react strongly to neurofibrillary tangles and senile plaques in brain tissue from patients with Alzheimer disease (27). In contrast, little or no reaction is observed in apparently healthy neurons of the same brain. Thus, it appears that the neurofibrillary tangles of Alzheimer's disease may be caused by the pentosidines. The modification of protein structure and function caused by arabinose could account for the biochemical and insolubility properties of the lesions of Alzheimer disease through the formation of protein crosslinks. Similar damage to the brains of autistic children might also be due to the pentosidines and neurofibrillary tangles have also been reported in the brain tissue of an individual with autism (28). It has been reported that frequent urinary tract infections are associated with more severe Alzheimer's disease (29). The use of antibiotics to treat urinary tract infections would of course lead to yeast overgrowth. I have found that urine arabinose is elevated in some cases of Alzheimer's disease and have received a report of a favorable response from antifungal therapy to treat Alzheimer's disease from a woman with a child with autism and a father with Alzheimer's disease.

Top

Prevention of pentosidine formation with high doses of vitamin B-6 and other vitamins?

Glutathione has been reported to inhibit pentosidine formation (24). Supplementation with the vitamins biotin, pyridoxal (B-6), and lipoic acid (whose function at protein epsilon amino groups may be blocked by pentosidines derived from arabinose) might also be beneficial. Addition of vitamin B-6 derivatives or vitamin C to proteins helps to prevent pentosidine formation (30). In fact, I suspect that the beneficial effects of vitamin B-6 in autism reported in multiple studies (31) may be mediated by prevention of pentosidine formation. Pamela Scott used the Super-Nuthera which contains high amounts of vitamin B-6 for her child who recovered from autism prior to starting antifungal therapy and I suspect that this reduced somewhat the effects of the yeast die-off reaction. One way to test this idea would be to do a formal study to see if vitamin B-6 supplementation was less effective in treating autistic symptoms after antifungal therapy compared to supplementation before antifungal therapy.

Figure 12

Other compounds called furans that are occasionally elevated in the urine of autistic children are probably derived from fungus such as Aspergillus (32-34) rather than yeast although it is possible they may be produced by yeast as well. The names of these compounds are called 5-hydroxymethyl-2-furoic acid, furan-2,5-carboxylic acid, and furancarbonylglycine. The concentration of furan compounds in the urine also dropped markedly in children with elevated values after nystatin therapy, indicating to me a probable yeast and/or fungal origin of these compounds. Other investigators (35,36) noted that these compounds increased after sugar consumption and assumed that these compounds were sugar products of human metabolism but neglected to take into account the Japanese work and the role of gastrointestinal microorganisms in modification of sugars in the food. My interpretation is that these compounds may be derived from sugar but that they are converted to these furan products by the metabolism of yeast and/or fungi in the intestinal tract.

Top

References

  1. Scriver C et al. The hyperphenylalaninemias. In: The Metabolic Basis of Inherited Disease. Volume 1.Sixth edition. Scriver C et al, editors. McGraw-Hill, NY pgs495-546,1989.
  2. Shaw W, Kassen E, and Chaves E. Increased excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 41:1094-1104, 1995.
  3. Gosselin R et al. Clinical toxicology of commercial products, 5th ed. Williams and Wilkins, Baltimore, MD,1984, pg 200.
  4. Gold H and Zahm W. A method for the evaluation of laxative agents in constipated human subjects with a study of the comparative laxative potency of fumarates, sodium tartrate, and magnesium acid citrate. J Am Pharm Assoc 32:173-178,1943.
  5. Bodansky O et al. The toxicity and laxative action of sodium fumarate. J Am Pharmaceut Assoc 31: 1-8, 1942.
  6. Robertson B and Lonneell. Human tartarate nephropathy. Report of a fatal case. Acta Pathol. Microbiol. Scand. 74:305-310, 1968.
  7. Campbell S and Poddell R. Fibromyalgia Network. April 1997. pg 8.
  8. Teitelbaum J. From Fatigued to Fantastic. Avery Publishing Group, Garden City, NY, pgs 8,11,12,41-43,44,50,51,67, 1996.
  9. Lewis R. Sr. Food Additives Handbook. Van Nostrand Reinhold, NY,1989. Pg.417.
  10. Mahler H and Cordes E. Biological Chemistry. Harper and Row, NY, 1966, pgs 525-553.
  11. Holzschlag Molly. CoQ10, malic acid, and magnesium may improve CFIDS/FM symptoms. The CFIDS Chronicle, Summer 1993.
  12. Abraham G et al. Management of fibromyalgia: Rationale for the use of magnesium and malic acid. J Nutr Med 3: 49-50, 1992.
  13. Russell J et al. Treatment of fibromyalgia syndrome with super malic: a randomized, double-blinded, placebo controlled, crossover pilot study. J Rheumatol 22: 953-8, 1995.
  14. St Amand RP. Exploring the fibromyalgia connection. The Vulvar Pain Newsletter. Fall 1996, 4-6.
  15. Kiehn T. et al. Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science 206: 577-580, 1979.
  16. Wong B, Brauer K, Clemens J, and Beggs S. Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine. Infect Immunol 58:283-288, 1990.
  17. Larsson, Lennart. Determination of microbial chemical markers by gas chromatography-mass spectrometry-potential for diagnosis and studies on metabolism in situ. APMIS 102: 161-169, 1994.
  18. Roboz J and Katz R. Diagnosis of disseminated candidiasis based on serum D/L arabinitol ratios using negative chemical ionization mass spectrometry. J Chromatog 575: 281-286, 1992.
  19. Gitzelman R, Steinmann B, and Van der Berghe G. Disorders of fructose metabolism. In: The Metabolic Basis of Inherited Disease. pgs 399-424,1989. 6th edition. Edited by C Scriver. McGraw Hill, NY, NY.
  20. Horowitz B, Edelstein S, and Lipman L. Sugar chromatography studies in recurrent vulvovaginitis. J Reproductive Medicine 29:441-443, 1984.
  21. Varma R and Hoshino A. Serum glycoproteins in schizophrenia. Carbohydrate Research 82:343-351, 1980.
  22. Varma R, Michos G, Gordon B, Varma RS, and Shirey R. Serum glycoproteins in children with schizophrenia and conduct and adjustment disorders. Biochem Med 30:206-214, 1983.
  23. Wells-Knecht KJ et al. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34: 3702-9, 1995.
  24. Nagaraj RH et al. Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase. Diabetes 43: 580-6, 1994.
  25. Sell D and Monnier V. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264: 21597-21602, 1989.
  26. Mahler H and Cordes E. Biological Chemistry. Harper and Row, NY, 1966, pgs 322-375.
  27. Smith MA et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714 , 1994.
  28. Hof PR et al. Neuropathological observations in a case of autism presenting with self-injury behavior. Acta Neuropathol (Berl) 82: 321-6, 1991.
  29. Soininen H et al. Circulating immune complexes in sera from patients with Alzheimer's disease and subjects with age-associated memory impairment. J Neural Transmission 6:179-188, 1993.
  30. Khatami M et al. Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. Life Sci 43:1725-31, 1988.
  31. Rimland B. New hope for safe and effective treatments for autism. Autism Research Review International 8: 3, 1994.
  32. Sumiki Y. Fermentation products of mold fungi. IV. Aspergillus glaucus.I. J Agr Chem Soc Jap 5 : 10, 1929.
  33. Sumuki Y. Fermentation products of molds. J Agr Chem Soc Jap 7: 819, 1931.
  34. Kawarda A, Takahoshi N, Kitamura H, Seta Y, Takai M, and Tamura S. Biochemical studies on bakanae fungus. Bull Agr Soc Jap 19: 84,1955.
  35. Mrochek J and Rainey W. Identification and biochemical significance of substituted furans in human urine. Clin Chem 18: 821-828, 1972.
  36. Pettersen J and Jellum E. The identification and metabolic origin of 2-furoylglycine and 2,5-furandicarboxylic acid in human urine. Clin ChimActa41:199-207, 1972.

Buy The newest version (2002) of this book online!

Top

Biological Treatments for Autism and PDD Online > Chapter 3: Part I | Part II | Part III